Bacterial vaginosis secondary prevention
Jump to navigation
Jump to search
|
Bacterial vaginosis Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Bacterial vaginosis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Bacterial vaginosis secondary prevention |
|
Risk calculators and risk factors for Bacterial vaginosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Effective measure for the secondary prevention of infective conjunctivitis include maintaining vaginal pH at 4.5, bacteriotherapy, avoid douching and change in the method of contraception.[1][2][3][4]
Secondary prevention
Effective measure for the secondary prevention of infective conjunctivitis include:[1][2][3][4]
- Maintaining vaginal pH at 4.5
- Use intravaginal lactate gel
- Bacteriotherapy
- Intravaginal and oral administration of lactobacilli
- Stop douching
- Changing the method of contraception
References
- ↑ 1.0 1.1 Wilson J (2004). "Managing recurrent bacterial vaginosis". Sex Transm Infect. 80 (1): 8–11. PMC 1758381. PMID 14755028.
- ↑ 2.0 2.1 Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM; et al. (2013). "Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use". Clin Infect Dis. 56 (6): 777–86. doi:10.1093/cid/cis1030. PMID 23243173.
- ↑ 3.0 3.1 Reid G, Beuerman D, Heinemann C, Bruce AW (2001). "Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora". FEMS Immunol Med Microbiol. 32 (1): 37–41. PMID 11750220.
- ↑ 4.0 4.1 Andersch B, Lindell D, Dahlén I, Brandberg A (1990). "Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel". Gynecol Obstet Invest. 30 (2): 114–9. PMID 2245947.